Galecto Inc reports results for the quarter ended in September - Earnings Summary

Damora Therapeutics

09/11/2022 10:16

* Galecto Inc  GLTO.OQ  reported a quarterly adjusted loss
of 54
cents​​ per share for the quarter ended in September. The lone
analyst forecast for the quarter was for a loss of 68 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galecto Inc's reported EPS for the quarter was a loss
of 54
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Galecto Inc shares had held steady so far this quarter and
lost 37.6% so far this year.
    * The company reported a quarterly loss of $13.73 million.
    * Wall Street's median 12-month price target for Galecto Inc
is
$10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:16 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.68          -0.54          Beat
 Jun. 30 2022      -0.69          -0.67          Beat
 Dec. 31 2021      -0.56          -0.53          Beat